Organovo Holdings Inc (ONVO)
1.04
+0.03
(+2.97%)
USD |
NASDAQ |
Mar 28, 14:24
Organovo Holdings Price to Book Value: 1.689 for March 28, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 27, 2024 | 1.640 |
March 26, 2024 | 1.705 |
March 25, 2024 | 1.673 |
March 22, 2024 | 1.657 |
March 21, 2024 | 1.673 |
March 20, 2024 | 1.673 |
March 19, 2024 | 1.705 |
March 18, 2024 | 1.803 |
March 15, 2024 | 1.705 |
March 14, 2024 | 1.608 |
March 13, 2024 | 1.640 |
March 12, 2024 | 1.640 |
March 11, 2024 | 1.640 |
March 08, 2024 | 1.657 |
March 07, 2024 | 1.640 |
March 06, 2024 | 1.657 |
March 05, 2024 | 1.673 |
March 04, 2024 | 1.673 |
March 01, 2024 | 1.657 |
February 29, 2024 | 1.657 |
February 28, 2024 | 1.640 |
February 27, 2024 | 1.592 |
February 26, 2024 | 1.601 |
February 23, 2024 | 1.624 |
February 22, 2024 | 1.640 |
Date | Value |
---|---|
February 21, 2024 | 1.624 |
February 20, 2024 | 1.671 |
February 16, 2024 | 1.657 |
February 15, 2024 | 1.657 |
February 14, 2024 | 1.722 |
February 13, 2024 | 1.640 |
February 12, 2024 | 1.819 |
February 09, 2024 | 1.462 |
February 08, 2024 | 1.624 |
February 07, 2024 | 1.575 |
February 06, 2024 | 1.681 |
February 05, 2024 | 1.657 |
February 02, 2024 | 1.673 |
February 01, 2024 | 1.689 |
January 31, 2024 | 1.657 |
January 30, 2024 | 1.673 |
January 29, 2024 | 1.738 |
January 26, 2024 | 1.657 |
January 25, 2024 | 1.640 |
January 24, 2024 | 1.673 |
January 23, 2024 | 1.657 |
January 22, 2024 | 1.623 |
January 19, 2024 | 1.592 |
January 18, 2024 | 1.655 |
January 17, 2024 | 1.711 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4913
Minimum
Dec 29 2022
7.442
Maximum
Feb 11 2021
1.710
Average
1.477
Median
Price to Book Value Benchmarks
CEL-SCI Corp | 8.065 |
AIM ImmunoTech Inc | 1.058 |
IGC Pharma Inc | 2.886 |
NovaBay Pharmaceuticals Inc | 0.1347 |
Protalix BioTherapeutics Inc | 2.764 |
Price to Book Value Related Metrics
PEG Ratio | -0.0077 |
Price | 1.04 |
Earnings Yield | -208.7% |
Market Cap | 10.44M |
PEGY Ratio | -0.0077 |